FI781753A7 - Nya ftalazinderivat - Google Patents

Nya ftalazinderivat Download PDF

Info

Publication number
FI781753A7
FI781753A7 FI781753A FI781753A FI781753A7 FI 781753 A7 FI781753 A7 FI 781753A7 FI 781753 A FI781753 A FI 781753A FI 781753 A FI781753 A FI 781753A FI 781753 A7 FI781753 A7 FI 781753A7
Authority
FI
Finland
Prior art keywords
phthalazinder
ribs
new
phthalazinder ribs
new phthalazinder
Prior art date
Application number
FI781753A
Other languages
English (en)
Finnish (fi)
Inventor
Simon Fraser Campbell
John Christopher Danilewicz
Anthony Garth Evans
Allan Leslie Ham
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI781753A7 publication Critical patent/FI781753A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI781753A 1977-06-03 1978-06-01 Nya ftalazinderivat FI781753A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2358277 1977-06-03

Publications (1)

Publication Number Publication Date
FI781753A7 true FI781753A7 (fi) 1978-12-04

Family

ID=10198020

Family Applications (1)

Application Number Title Priority Date Filing Date
FI781753A FI781753A7 (fi) 1977-06-03 1978-06-01 Nya ftalazinderivat

Country Status (29)

Country Link
US (1) US4289772A (en:Method)
JP (1) JPS5416488A (en:Method)
AR (2) AR222013A1 (en:Method)
AT (2) AT362792B (en:Method)
AU (1) AU505373B1 (en:Method)
BE (1) BE867727A (en:Method)
CA (1) CA1111850A (en:Method)
DD (1) DD137355A5 (en:Method)
DE (1) DE2824064A1 (en:Method)
DK (1) DK248078A (en:Method)
EG (1) EG13527A (en:Method)
ES (4) ES470470A1 (en:Method)
FI (1) FI781753A7 (en:Method)
FR (1) FR2392986A1 (en:Method)
GB (1) GB2000136B (en:Method)
GR (1) GR74402B (en:Method)
HU (1) HU179745B (en:Method)
IL (1) IL54842A (en:Method)
IN (3) IN148482B (en:Method)
IT (1) IT1094944B (en:Method)
LU (1) LU79761A1 (en:Method)
NL (1) NL7806016A (en:Method)
NO (1) NO781935L (en:Method)
NZ (1) NZ187453A (en:Method)
PL (3) PL116437B1 (en:Method)
PT (1) PT68126A (en:Method)
SE (1) SE7806519L (en:Method)
SU (2) SU856383A3 (en:Method)
ZA (1) ZA783183B (en:Method)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370328A (en) * 1977-11-03 1983-01-25 Pfizer Inc. Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
IL59619A0 (en) * 1979-03-28 1980-06-30 Pfizer Phthalazine derivatives,their preparation and pharmaceutical compositions containing them
ES499716A0 (es) * 1980-03-01 1982-05-01 Wyeth John & Brother Ltd Un procedimiento para la preparacion de nuevos derivados de piperidina
GB8320958D0 (en) * 1983-08-03 1983-09-07 Pfizer Ltd Quinazoline cardiac stimulants
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
US4882354A (en) * 1987-12-16 1989-11-21 Norwich Eaton Pharmaceuticals, Inc. N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
JP3169188B2 (ja) * 1991-01-31 2001-05-21 杏林製薬株式会社 カルバミン酸誘導体及びその製造方法
US5300515A (en) * 1991-01-31 1994-04-05 Kyorin Pharmaceutical Co., Ltd. Carbamic acid derivatives and method for preparing the same
EP0621267A1 (en) * 1993-04-07 1994-10-26 Shell Internationale Researchmaatschappij B.V. Spiropiperidine derivatives and their use as fungicides
US5728712A (en) * 1995-05-19 1998-03-17 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
KR100485249B1 (ko) * 1996-08-20 2005-09-09 에자이 가부시키가이샤 축합피리다진계화합물의발기기능부전증치료제
US20030186963A1 (en) 2001-09-14 2003-10-02 Dorwald Florencio Zaragoza Substituted piperidines
US20040224986A1 (en) * 2002-08-16 2004-11-11 Bart De Corte Piperidinyl targeting compounds that selectively bind integrins
PT1539739E (pt) * 2002-08-16 2011-01-05 Janssen Pharmaceutica Nv Compostos de piperidinilo que ligam selectivamente integrinas
US20060019975A1 (en) * 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
TW200630337A (en) 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
CA2625153A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
JP2009513672A (ja) 2005-10-31 2009-04-02 ブレインセルス，インコーポレイティド 神経発生のｇａｂａ受容体媒介調節
WO2007085954A2 (en) * 2006-01-27 2007-08-02 Pfizer Products Inc. Aminophthalazine derivative compounds
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US8247442B2 (en) 2006-03-29 2012-08-21 Purdue Pharma L.P. Benzenesulfonamide compounds and their use
WO2007118853A1 (en) 2006-04-13 2007-10-25 Euro-Celtique S.A. Benzenesulfonamide compounds and their use as blockers of calcium channels
US8937181B2 (en) 2006-04-13 2015-01-20 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
EP1900731A1 (de) * 2006-09-07 2008-03-19 Bayer Schering Pharma Aktiengesellschaft N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren
EP1903037A1 (de) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors
AU2007292848A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008124118A1 (en) 2007-04-09 2008-10-16 Purdue Pharma L.P. Benzenesulfonyl compounds and the use therof
AU2008285718A1 (en) 2007-08-07 2009-02-12 F. Hoffmann-La Roche Ag Pyrrolidine aryl-ether as NK3 receptor antagonists
CN101861302A (zh) 2007-08-22 2010-10-13 弗·哈夫曼-拉罗切有限公司 作为nk3受体拮抗剂的吡咯烷芳基-醚
EP2200982B1 (en) * 2007-09-14 2012-03-14 F. Hoffmann-La Roche AG Piperidine derivatives as nk3 receptor antagonists
US8765736B2 (en) 2007-09-28 2014-07-01 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AR077014A1 (es) 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
WO2022081661A1 (en) 2020-10-13 2022-04-21 Endeavor Biomedicines, Inc. Methods of treating fibrosis
CN113087654B (zh) * 2021-04-15 2022-12-23 苏州昊帆生物股份有限公司 哌啶-4-丁胺的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1094044A (en) * 1965-07-12 1967-12-06 Vantorex Ltd Phthalazine derivatives
GB1199768A (en) 1966-10-31 1970-07-22 Pfizer & Co C Nitrogen Heterocycles and process for their preparation
GB1293565A (en) * 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
GB1460389A (en) 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants

Also Published As

Publication number Publication date
PT68126A (en) 1978-07-01
CA1111850A (en) 1981-11-03
PL116420B1 (en) 1981-06-30
DK248078A (da) 1978-12-04
NL7806016A (nl) 1978-12-05
IN148482B (en:Method) 1981-03-07
IT1094944B (it) 1985-08-10
EG13527A (en) 1981-12-31
AR223999A1 (es) 1981-10-15
DE2824064A1 (de) 1978-12-14
JPS5416488A (en) 1979-02-07
ES470470A1 (es) 1979-09-01
ES478200A1 (es) 1980-01-01
GB2000136A (en) 1979-01-04
ES478199A1 (es) 1980-01-16
BE867727A (fr) 1978-12-01
ATA305080A (de) 1980-12-15
ES478201A1 (es) 1980-02-01
AT362792B (de) 1981-06-10
NZ187453A (en) 1980-12-19
IT7824106A0 (it) 1978-06-01
SU862826A3 (ru) 1981-09-07
SU856383A3 (ru) 1981-08-15
GB2000136B (en) 1982-01-06
ZA783183B (en) 1979-06-27
JPS5538351B2 (en:Method) 1980-10-03
IN149550B (en:Method) 1982-01-16
AR222013A1 (es) 1981-04-15
DD137355A5 (de) 1979-08-29
IN149973B (en:Method) 1982-06-19
FR2392986B1 (en:Method) 1982-07-16
US4289772A (en) 1981-09-15
FR2392986A1 (fr) 1978-12-29
GR74402B (en:Method) 1984-06-28
LU79761A1 (fr) 1980-01-22
AT363096B (de) 1981-07-10
PL116437B1 (en) 1981-06-30
PL207337A1 (pl) 1979-06-04
HU179745B (en) 1982-12-28
NO781935L (no) 1978-12-05
SE7806519L (sv) 1978-12-04
IL54842A0 (en) 1978-08-31
PL113208B1 (en) 1980-11-29
IL54842A (en) 1982-01-31
AU505373B1 (en) 1979-11-15
ATA400878A (de) 1980-11-15

Similar Documents

Publication Publication Date Title
FI781753A7 (fi) Nya ftalazinderivat
FI783863A7 (fi) Stilbenderivat
FI782530A7 (fi) Nya nitroimidazoler och foerfarande foer deras framstaellning
SE7806710L (sv) Nya karbostyrilderivat
FI782931A7 (fi) Nya aemnessammansaettningar
SE7802867L (sv) Nya 4-acylamino-fenyl-etanolaminer
SE7707734L (sv) Nya hydroxi-succinimido-estrar
FI783126A7 (fi) Xantinderivat
SE7807642L (sv) Nya 1-acyl-2-cyanaziridiner
FI782481A7 (fi) Foerfarande foer framstaellning av nya organiska foereningar
FI783327A7 (fi) Foerfarande foer framstaellning av nya kemiska foereningar
FI773717A7 (fi) Nya aminoalkoxifenylderivater
FI783846A7 (fi) Nya bredspektriga cefalosporinantibioter
SE7712387L (sv) Nya morfantridiner
SE7810050L (sv) Nya 7-azabensimidazoler
FI781779A7 (fi) Foerfarande foer framstaellning av nya nitroso-urinaemnen
FI780083A7 (fi) Nya ditienylalkylaminer och foerfarande foer deras framstaellning
FI772394A7 (fi) Nya behensyraestrar
FI782011A7 (fi) Nya imidazo-isokinolin-dioner
FI782039A7 (fi) Nya 2-pyridyl- och 2-pyrimidylaminobensoesyror
FI782228A7 (fi) Foerfarande foer framstaellning av nya bensopyranderivat
SE7804318L (sv) Nya naftyridiner
FI781886A7 (fi) Foerfarande foer framstaellning av nya pyridazinylhydrazoner
FI780269A7 (fi) Nya ergolinderivat
FI782994A7 (fi) Foerfarande foer framstaellning av nya piperazinopyrrolobensodiazepiner

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: PFIZER CORPORATION